Plasma β-endorphin response to exercise in patients with congestive heart failure

Chest

Volumn 111, Issue 1, 1997, Pages 19-22

  Perna, Gian Piero ^a   Modoni, Sergio ^a   Valle, Guido ^a   Stanislao, Mario ^a   Loperfido, Francesco ^b  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ENDORPHIN; NORADRENALIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; EXERCISE; EXERCISE TEST; HUMAN; NORADRENALIN BLOOD LEVEL; OXYGEN CONSUMPTION; PHYSICAL DISABILITY; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 0031020879     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.111.1.19     Document Type: Article

References (26)

1. Scadt JC, Gaddis RR. Endogenous opiate peptides may limit norcpinephrine release during hemorrhage. J Pharmacol Exp Ther 1982; 221:282-88
2. Holaday JW. Cardiovascular effects of endogenous opiate system. Ann Rev Pharmacol Toxicol 1983; 23:541-94
3. Martin WR. Pharmacology of opioids. P'harmacol Rev 1984; 35:283-323
4. Feuerstein G, Sirèn AL. The opioid system in cardiac and vascular regulation of normal and hypertensive states, Circulation 1987; 75:125-29
5. Schwarz L, Kindermann W. Beta-endorphin, adrcnocorticotropie hormone. cortisol and catecholamines during aerobic and anaerobic exercise. Eur J Appl Physiol 1990; 61:165-71
6. Francis GS. Neurohumoral mechanisms involved in congestive heart failure. Am J Cardiol 1985; 55(suppl 2):15A-21A
7. Packer M. Neurohumoral interaction and adaptations in congestive heart failure. Circulation 1988; 77:721-30
8. Parmley WW. Pathophysiology and current therapy of congestive heart failure. J Am Coll Cardiol 1989, 13:771-85
9. Francis GS, Benediet C, Johnstone DE. Comparison of neuroendocrine activation in patients with left ventricular congestive heart failure. Circulation 1990; 82:1724-29
10. Drexler H. Reduced exercise tolerance in chronic heart failure and its relationship to neurohumoral factors. Eur Heart J 1991; 12(suppl C):21-8
11. Francis GS, Goldsmith SR, Ziesche SM. et al. Response of plasma norepineplrine and epinephrine to dynamic exercise in patients with congestive heart failure. Am J Cardiol 1982; 49:1151-56
12. Rector TS, Olivari MT, Levine TB, et al. Predicting survival for an individual with congestive heart failure using plasma norepinephrine concentration. Am Heart J 1987; 114:148-52
13. Liang CS, Imai N, Stone CK, et al. The role of endogeneous opioids in congestive heart failure: effects of nalmefene on systemic and regional hemodynamics in dogs. Circulation 1987; 75:443-51
14. Kawashima S, Fukutake N, Nishian K. et al. Elevated plasma beta-endorphin levels in patients with congestive heart failure. J Am Coll Cardiol 1991; 17:53-8
15. Weber KT, Janicki JS, Mc Elroy PA. et al. Concepts and applications of cardiopuhnonary exercise testing. Chest 1988; 93:843-47
16. Wardlaw SL, Frantz AG. Measurement of beta endorphin in human plasma. J Clin Endocrinol Metab 1979; 48:176-80
17. Hussain MN, Beuedict CR. Radioenzymatic microassay for simultaneous estimations of dopamine. norepinephrine and epinephrine in plasma, urine and tissues. Clin Chem 1985; 31:861-64
18. Akil H, Watson SJ, Yonnu E. et al. Endogenous opioids: biology and function. Annn Rev Neurosci 1984; 17:223-55
19. Tilders FJH, Berembosch F, Smelik PG. Control of secretion of peptides related to adrenocortin. melanocyte-stimulating hormone and endorphin. Front Horm Res 1985; 14:161-96
20. Morley JE. The endocrinology of the opiates and opioid peptides. Metabolism 1981; 30:195-209
21. Konishi S, Tsunoo A, Otsuka M. Enkephalins presynaptically inhibit cholinergic transmission in sympathetic ganglia. Nature 1979; 282:515-16
22. Saiani L, Guidotti A. Opiate receptor-mediated inhibition of catecholamine release in primary cultures of bovine adrenal chromaffin cells. J Neurochem 1982; 39:1669-76
23. Surbey GD, Andrew GM, Cervenko FW, et al. Effects of naloxone on exercise performance. J Appl Physiol Respir Environ Exercise Physiol 1984; 57:674-79
24. Grossman A, Dutton JR. Endorphins: what are they? How are they measured? What is their role in exercise? Med Sci Sports Exerc 1985; 17:74-81
25. Johnson MW, Mitch WE, Wilcox CS. The cardiovascular actions of the morphine and the endogenous opioids peptides. Prog Cardiovasc Dis 1985; 27:435-50
26. Ledda F, Mantelli L, Corti V. et al. Inhibition of the cardiac response to sympathetic nerve stimulation of opioid peptides and its potentiation by morphine and metadone. Eur J Pharmacol 1984; 102:443-50